The University of Rhode Island has hired the founder of one of the state’s best-known biotechnology firms to lead researchers in the development of vaccines against malaria, AIDS and tuberculosis.

Annie S. De Groot, 53, is not leaving EpiVax Inc., the Providence-based company she helped create in 1998, building on software technology she developed at Brown University. She is president and chief executive officer of the company, which last year recorded $2.5 million in sales.

De Groot is also continuing to treat tuberculosis patients at Miriam Hospital and helping to open a free medical clinic in Olneyville that may offer a center on infectious disease.

Full Story: New lab will research vaccines Source: Providence Journal, February 24th, 2009 Author: Benjamin N. Gedan Added on February 24th, 2009 at 9:40 am, by Matt Mikula